Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control

S. Tereshchenko (Krashoyarsk, Russian Federation), M. Smolnikova (Krasnoyarsk, Russian Federation), V. Belenjuk (Krashoyarsk, Russian Federation), I. Novitsky (Krashoyarsk, Russian Federation)

Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Session: Biomarkers and risk factors in childhood asthma
Session type: E-poster
Number: 3076

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Tereshchenko (Krashoyarsk, Russian Federation), M. Smolnikova (Krasnoyarsk, Russian Federation), V. Belenjuk (Krashoyarsk, Russian Federation), I. Novitsky (Krashoyarsk, Russian Federation). Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control. 3076

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007


Soluble RAGE is deficient in neutrophilic asthma and COPD
Source: Eur Respir J 2012; 39: 721-729
Year: 2012



Reduced soluble receptor for advanced glycation end-products in COPD
Source: Eur Respir J 2011; 37: 516-522
Year: 2011



Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012


Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

A role of the advanced glycation end products (AGEs) in epithelial-myofibroblast transition
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010

Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Importance of the receptor for advanced glycation end products in the respiratory mechanics
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012

Plasma advanced glycation end-products and skin autofluorescence are increased in COPD
Source: Eur Respir J 2014; 43: 430-438
Year: 2013



Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006

Associations between plasma sRAGE, esRAGE and AGEs in COPD
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013

Measures of lung function and their relationship with advanced glycation end-products
Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019
Year: 2020



Increased expression of receptor for advanced glycation end products in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014


Advanced glycation endproducts are increased in lung tissue from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review
Source: Eur Respir Rev, 28 (151) 180096; 10.1183/16000617.0096-2018
Year: 2019



Plasma levels of soluble RAGE are lower in COPD
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012


Receptor of advanced glycation end products in childhood asthma exacerbation
Source: International Congress 2016 – Paediatric asthma: from amniotic fluid to dirty streets
Year: 2016